“…Recently, a number of risk assessment procedures have been proposed to cope with the issue of spread of CEC in the environment. For example, different integrated modelling approaches have shown the feasibility of assessing risk for clarithromycin, sulfamethoxazole, diclofenac, ibuprofen, paracetamol, carbamazepine, furosemide, 17-α ethinylestradiol, 17-β estradiol, estrone, perfluorooctanoic acid, perfluorooctane sulfonate, triclosan and polyaniline-based compounds [ 29 , 30 , 31 ]. All models accommodate temporal and spatial dynamics of environmental conditions (e.g., air, soil and water temperature, water and soil pH, sunlight intensity, etc.…”